Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma
Clinical trial NCT07665190 · RECRUITING
Trial details
- NCT number
- NCT07665190
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-10-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.